Literature DB >> 3348112

Choosing death. Withdrawal from chronic dialysis without medical reason.

J C Roberts1, C M Kjellstrand.   

Abstract

We analyzed patients who died on chronic dialysis because they stopped the treatment, although there was no technical dialysis complication or new medical complication. These patients preferred death to the stress of dialysis. This occurred in 26/1766 (1.5%) patients, and was responsible for 26/704 (4%) of all deaths. We compared these 26 patients to 40 competent patients who discontinued treatment when a medical complication arose. The patients were similar in most respects (age, sex, diagnosis, duration of dialysis, living situation, and type of dialysis) and had the same number of medical complications when starting dialysis. However, the patients who stopped dialysis were more often on home dialysis, 8/24 vs. 3/40 of the other patients (p less than 0.05). Overall, stopping was three times more common in home than in center patients (3.0% vs. 1.1%) (p less than 0.02). Relatives responding to a written interview felt that nurses and social workers but not physicians had been helpful in the difficult time surrounding the patient's decision and death. This study indicates that particularly home dialysis patients are at a high risk of discontinuing dialysis because of the stress of the dialysis procedure. A realistic introduction to and realization of their dialysis problems, better training and better psychological support, particularly from physicians, are necessary to eradicate this avoidable cause of death in chronic dialysis patients.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; Hennepin County Medical Center (MN); Professional Patient Relationship

Mesh:

Year:  1988        PMID: 3348112

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  5 in total

1.  On discontinuing dialysis.

Authors:  J Wight
Journal:  J Med Ethics       Date:  1993-06       Impact factor: 2.903

2.  Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.

Authors:  Nelson Ferreira; Hjalte Gram; Zachary A Sorrentino; Emil Gregersen; Sissel Ida Schmidt; Lasse Reimer; Cristine Betzer; Clara Perez-Gozalbo; Marjo Beltoja; Madhu Nagaraj; Jie Wang; Jan S Nowak; Mingdong Dong; Katarina Willén; Ersoy Cholak; Kaare Bjerregaard-Andersen; Nicolas Mendez; Prakruti Rabadia; Mohammad Shahnawaz; Claudio Soto; Daniel E Otzen; Ümit Akbey; Morten Meyer; Benoit I Giasson; Marina Romero-Ramos; Poul Henning Jensen
Journal:  Acta Neuropathol       Date:  2021-05-12       Impact factor: 17.088

Review 3.  Evidence of distinct α-synuclein strains underlying disease heterogeneity.

Authors:  Sara A M Holec; Amanda L Woerman
Journal:  Acta Neuropathol       Date:  2020-05-21       Impact factor: 17.088

Review 4.  Changing landscape of dialysis withdrawal in patients with kidney failure: Implications for clinical practice.

Authors:  Jenny H C Chen; Wai H Lim; Prue Howson
Journal:  Nephrology (Carlton)       Date:  2022-03-06       Impact factor: 2.358

Review 5.  Tau strains shape disease.

Authors:  Jaime Vaquer-Alicea; Marc I Diamond; Lukasz A Joachimiak
Journal:  Acta Neuropathol       Date:  2021-04-08       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.